[
  {
    "question": "What is the focus of the 2023 International Evidence-based Guideline?",
    "answer": "The focus of the 2023 International Evidence-based Guideline is the assessment and management of Polycystic Ovary Syndrome (PCOS).",
    "is_verified": 1
  },
  {
    "question": "How many recommendations and practice points are included in the guidelines?",
    "answer": "The guidelines include 254 recommendations and practice points.",
    "is_verified": 1
  },
  {
    "question": "What is the aim of the international evidence-based guidelines for PCOS?",
    "answer": "The aim is to promote consistent, evidence-based care and improve the experience and health outcomes for individuals with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What is PCOS?",
    "answer": "PCOS stands for Polycystic Ovary Syndrome, a hormonal disorder common among women of reproductive age. It is characterized by irregular menstrual periods, excess hair growth, acne, and obesity. The condition can lead to various health issues, including diabetes and heart disease.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of the 2018 International PCOS Guideline?",
    "answer": "The 2018 International PCOS Guideline is significant because it provides evidence-based diagnostic criteria for PCOS, enhancing the accuracy of diagnosis and promoting consistency of care across 196 countries. It integrates multidisciplinary and consumer perspectives, although it acknowledges that the quality of evidence is generally low.",
    "is_verified": 1
  },
  {
    "question": "What are the challenges mentioned regarding the diagnosis of PCOS?",
    "answer": "The challenges regarding the diagnosis of PCOS include delayed diagnosis, inadequate meeting of the needs of those with PCOS, and persistent evidence-practice gaps despite the existence of guidelines.",
    "is_verified": 1
  },
  {
    "question": "What framework was applied in the 2023 International Evidence-based Guideline update?",
    "answer": "The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied in the 2023 International Evidence-based Guideline update to assess evidence quality, feasibility, acceptability, cost, implementation, and recommendation strength.",
    "is_verified": 1
  },
  {
    "question": "What types of professionals were involved in the guideline development process?",
    "answer": "The guideline development process involved a range of professionals including paediatricians, endocrinologists, gynaecologists, primary care physicians, reproductive endocrinologists, obstetricians, psychiatrists, psychologists, dietitians, and exercise specialists.",
    "is_verified": 1
  },
  {
    "question": "What are the key updates in the assessment and management of PCOS?",
    "answer": "The key updates include: i) further refinement of individual diagnostic criteria, a simplified diagnostic algorithm, and inclusion of anti-Müllerian hormone (AMH) levels as an alternative to ultrasound in adults only; ii) strengthening recognition of broader features of PCOS including metabolic risk factors, cardiovascular disease, sleep apnea, very high prevalence of psychological features, and high risk status for adverse outcomes during pregnancy; iii) emphasizing the poorly recognized, diverse burden of disease and the need for greater healthcare professional education, evidence-based patient information, improved models of care and shared decision making to improve patient experience, alongside greater research; iv) maintained emphasis on healthy lifestyle, emotional wellbeing and quality of life, with awareness and consideration of weight stigma; and v) emphasizing evidence-based medical therapy and cheaper and safer fertility management.",
    "is_verified": 1
  },
  {
    "question": "What is the focus of the 2023 International Guideline mentioned in the excerpt?",
    "answer": "The 2023 International Guideline focuses on the Assessment and Management of Polycystic Ovary Syndrome (PCOS), providing clinicians and patients with clear advice on best practices based on available evidence, expert input, and consumer preferences.",
    "is_verified": 1
  },
  {
    "question": "What organizations supported the funding of the guideline development?",
    "answer": "The guideline development was primarily funded by the Australian Government via the National Health Medical Research Council (NHMRC), with support from the American Society for Reproductive Medicine, Endocrine Society, European Society for Human Reproduction and Embryology, and the Society for Endocrinology.",
    "is_verified": 1
  },
  {
    "question": "What type of research is indicated as necessary in the excerpt?",
    "answer": "The excerpt indicates that significantly greater research is needed in the area of Polycystic Ovary Syndrome (PCOS), which is described as a neglected yet common condition.",
    "is_verified": 1
  },
  {
    "question": "What does the guideline support in terms of dissemination?",
    "answer": "The guideline is supported by a comprehensive multifaceted dissemination and translation program, which includes an integrated evaluation program to ensure effective implementation.",
    "is_verified": 1
  },
  {
    "question": "What are the affiliations and financial disclosures of the speakers mentioned in the excerpt?",
    "answer": "The excerpt lists various financial disclosures and affiliations of speakers related to medical organizations and pharmaceutical companies. These include speaker's fees, consulting fees, travel support, and advisory board memberships for companies such as Ferring, Roche Diagnostics, Merck, Novo Nordisk, and Boehringer Ingelheim. Additionally, it mentions grants received from Merck Serono Ltd. and the peer review process of guidelines related to health economics and reproductive medicine.",
    "is_verified": 1
  },
  {
    "question": "What medical condition is referenced in the excerpt?",
    "answer": "The excerpt references Polycystic Ovary Syndrome (PCOS) as a key term, indicating that the guidelines discussed are related to the assessment and management of this condition.",
    "is_verified": 1
  },
  {
    "question": "What is Polycystic Ovary Syndrome (PCOS)?",
    "answer": "Polycystic Ovary Syndrome (PCOS) is the most common endocrinopathy affecting reproductive-aged women, with impacts across the lifespan from adolescence to post menopause. It has a prevalence of between 10 to 13%.",
    "is_verified": 1
  },
  {
    "question": "What are the goals of the guideline for the management of PCOS?",
    "answer": "The guideline aims to ensure that women with PCOS receive optimal, evidence-based care that meets their needs and improves health outcomes. It emphasizes improved education and awareness of healthcare professionals, partnership in care, and empowerment of women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What factors are considered in the management of PCOS according to the guideline?",
    "answer": "The management of PCOS considers personal characteristics, preferences, culture, values, and resource availability across different settings.",
    "is_verified": 1
  },
  {
    "question": "What is PCOS?",
    "answer": "Polycystic Ovary Syndrome (PCOS) is a complex condition characterized by a heterogeneous clinical presentation that includes reproductive, metabolic, and psychological features.",
    "is_verified": 1
  },
  {
    "question": "What are the common issues faced by women with PCOS?",
    "answer": "Women with PCOS often experience delayed diagnosis and dissatisfaction with care, which can impact their overall health and quality of life.",
    "is_verified": 1
  },
  {
    "question": "What is the purpose of the 2018 International Evidence-based Guideline for PCOS?",
    "answer": "The purpose of the guideline is to provide evidence-based recommendations for the assessment and management of PCOS, aiming to improve the lives of those affected by the condition worldwide.",
    "is_verified": 1
  },
  {
    "question": "What does the guideline aim to achieve?",
    "answer": "The guideline aims to reduce worldwide variation in care for PCOS, promote high-quality clinical service provision, and improve health outcomes and quality of life for women with the syndrome.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of the guideline development process mentioned?",
    "answer": "The guideline is developed through a rigorous, AGREEII-compliant process, ensuring that it is based on high-quality evidence and can be adapted to different health systems.",
    "is_verified": 1
  },
  {
    "question": "What is the focus of the 2023 International Evidence-based Guideline mentioned in the excerpt?",
    "answer": "The focus of the 2023 International Evidence-based Guideline is the assessment and management of Polycystic Ovary Syndrome (PCOS).",
    "is_verified": 1
  },
  {
    "question": "What areas are covered by the five guideline development groups (GDGs) mentioned in the excerpt?",
    "answer": "The five guideline development groups (GDGs) cover the following areas: i) Screening, diagnostic and risk assessment and life stage; ii) Psychological features and models of care; iii) Lifestyle management; iv) Management of nonfertility features; and v) Assessment and management of infertility.",
    "is_verified": 1
  },
  {
    "question": "Which organizations partnered in the development of the guideline for PCOS?",
    "answer": "The organizations that partnered in the development of the guideline for PCOS include the Australian National Health and Medical Research Council (NHMRC), the American Society for Reproductive Medicine, the Endocrine Society, the European Society of Endocrinology, and the European Society of Human Reproduction and Embryology.",
    "is_verified": 1
  },
  {
    "question": "What is the focus of the guideline mentioned in the excerpt?",
    "answer": "The guideline focuses on equity, cultural and ethnic diversity, avoidance of stigma, and inclusivity in healthcare practices.",
    "is_verified": 1
  },
  {
    "question": "What are the categories of recommendations provided in the guideline for PCOS?",
    "answer": "The categories of recommendations for PCOS include Evidence Based Recommendations (EBR), Consensus Recommendations (CR), and Practice Points (PP). EBR indicates sufficient evidence to inform a recommendation, CR indicates recommendations made in the absence of adequate evidence, and PP includes implementation considerations based on the evidence.",
    "is_verified": 1
  },
  {
    "question": "What framework is mentioned for assessing the quality of guidelines?",
    "answer": "The AGREE-II tool is mentioned for quality guideline assessment, along with the Research Integrity in Guideline Development (RIGID) framework and the Trustworthiness in Randomised Controlled Trials (TRACT) checklist.",
    "is_verified": 1
  },
  {
    "question": "What does the GRADE framework consider in guideline recommendations?",
    "answer": "The GRADE framework considers evidence quality and grading of recommendations in the development of guidelines.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of the evidence synthesis methods outlined in the guideline?",
    "answer": "The evidence synthesis methods are significant as they follow best practices and ensure that the recommendations are based on a thorough review of available evidence.",
    "is_verified": 1
  },
  {
    "question": "What is PCOS?",
    "answer": "PCOS stands for polycystic ovary syndrome, which is a hormonal disorder common among women of reproductive age. It is characterized by irregular menstrual periods, excess hair growth, acne, and obesity. Women with PCOS may also have difficulty getting pregnant due to irregular ovulation or failure to ovulate. The condition is associated with insulin resistance and can lead to long-term health issues such as diabetes and heart disease.",
    "is_verified": 1
  },
  {
    "question": "What is the purpose of the International Evidence-based Guideline for the Assessment and Management of PCOS?",
    "answer": "The purpose of the International Evidence-based Guideline for the Assessment and Management of PCOS is to provide a high quality, reliable source of international evidence-based recommendations to guide consistent clinical practice and to empower women with evidence-based information.",
    "is_verified": 1
  },
  {
    "question": "How many evidence-based recommendations does the guideline provide?",
    "answer": "The guideline provides 77 evidence-based recommendations and 54 consensus recommendations, with 123 practice points underpinned by a technical report on evidence synthesis and GRADE detailed quality categories.",
    "is_verified": 1
  },
  {
    "question": "What does GRADE stand for in the context of medical guidelines?",
    "answer": "GRADE stands for Grading of Recommendations, Assessment, Development, and Evaluation, which is a framework used to assess the quality of evidence and strength of recommendations in clinical practice guidelines.",
    "is_verified": 1
  },
  {
    "question": "What are the categories of evidence quality according to GRADE?",
    "answer": "The categories of evidence quality according to GRADE are: High (very confident), Moderate (moderate confidence), Low (limited confidence), and Very Low (very little confidence) in the effect estimate.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of the International PCOS Guideline 2023?",
    "answer": "The International PCOS Guideline 2023 provides updated recommendations for the diagnosis and management of Polycystic Ovary Syndrome (PCOS), which is a common endocrine disorder affecting women of reproductive age. These guidelines are important for healthcare providers to ensure that patients receive evidence-based care and effective treatment options for managing symptoms and associated health risks.",
    "is_verified": 1
  },
  {
    "question": "What are the diagnostic criteria for irregular menstrual cycles in adolescents?",
    "answer": "Irregular menstrual cycles in adolescents are defined as: Normal in the first year post menarche as part of the pubertal transition; 1 to < 3 years post menarche: < 21 or > 45 days; 3 years post menarche to perimenopause: < 21 or > 35 days or < 8 cycles per year; 1 year post menarche: > 90 days for any one cycle; Primary amenorrhea by age 15 or > 3 years post thelarche (breast development).",
    "is_verified": 1
  },
  {
    "question": "What should be considered when diagnosing PCOS in adolescents with irregular menstrual cycles?",
    "answer": "When irregular menstrual cycles are present, a diagnosis of PCOS should be considered and assessed according to the PCOS Guidelines. Additionally, the value and optimal timing of assessment and diagnosis of PCOS should be discussed with the patient and their parent/s or guardian/s, considering diagnostic challenges at this life stage and psychosocial and cultural factors.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation for adolescents who have features of PCOS but do not meet diagnostic criteria?",
    "answer": "For adolescents who have features of PCOS but do not meet diagnostic criteria, an 'increased risk' could be considered, and reassessment is advised at or before full reproductive maturity, 8 years post menarche. This includes those with PCOS features before combined oral contraceptive pill (COCP) commencement, those with persisting features, and those with significant weight gain in adolescence.",
    "is_verified": 1
  },
  {
    "question": "How can ovulatory dysfunction be confirmed in adolescents?",
    "answer": "Ovulatory dysfunction can still occur with regular cycles, and if anovulation needs to be confirmed, serum progesterone levels can be measured.",
    "is_verified": 1
  },
  {
    "question": "What is biochemical hyperandrogenism and how is it assessed in the diagnosis of PCOS?",
    "answer": "Biochemical hyperandrogenism is assessed by measuring total and free testosterone levels. Healthcare professionals should use these measurements to diagnose polycystic ovary syndrome (PCOS). Free testosterone can be estimated using the calculated free androgen index.",
    "is_verified": 1
  },
  {
    "question": "What additional hormones may be measured if testosterone levels are not elevated in suspected cases of PCOS?",
    "answer": "If testosterone or free testosterone levels are not elevated, healthcare professionals could consider measuring androstenedione and dehydroepiandrosterone sulfate (DHEAS), although these have poorer specificity and a greater age-associated decrease in DHEAS levels.",
    "is_verified": 1
  },
  {
    "question": "What laboratory methods are recommended for measuring testosterone and related hormones?",
    "answer": "Laboratories should use validated, highly accurate tandem mass spectrometry (LC-MS/MS) assays for measuring total testosterone and, if needed, for androstenedione and DHEAS. Free testosterone should be assessed by calculation, equilibrium dialysis, or ammonium sulfate precipitation.",
    "is_verified": 1
  },
  {
    "question": "Why are LC-MS/MS assays preferred over direct immunoassays for assessing testosterone?",
    "answer": "LC-MS/MS assays are preferred because direct immunoassays (such as radiometric and enzyme-linked assays) have limited accuracy and demonstrate poor sensitivity and precision for diagnosing hyperandrogenism in PCOS.",
    "is_verified": 1
  },
  {
    "question": "What challenges exist in assessing biochemical hyperandrogenism in women on the combined oral contraceptive pill (COCP)?",
    "answer": "It is difficult to reliably assess biochemical hyperandrogenism in women on the COCP because the pill increases sex hormone-binding globulin and reduces gonadotrophin-dependent androgen production. If assessment is imperative, the COCP should be withdrawn for a minimum of three months, and alternative contraception should be managed during this time.",
    "is_verified": 1
  },
  {
    "question": "What is the role of repeated androgen measures in the ongoing assessment of PCOS in adults?",
    "answer": "Repeated androgen measures for the ongoing assessment of PCOS in adults have a limited role.",
    "is_verified": 1
  },
  {
    "question": "At what age do androgen levels typically reach adult ranges in adolescents?",
    "answer": "In most adolescents, androgen levels reach adult ranges at 12-15 years of age.",
    "is_verified": 1
  },
  {
    "question": "What are some causes of hyperandrogenaemia other than PCOS?",
    "answer": "Causes of hyperandrogenaemia other than PCOS include ovarian and adrenal neoplastic growths, congenital adrenal hyperplasia, Cushing’s syndrome, ovarian hyperthecosis (after menopause), iatrogenic causes, and syndromes of severe insulin resistance.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of clinical history in assessing androgen-secreting tumours?",
    "answer": "The clinical history of time of onset and/or rapid progression of symptoms is critical in assessing for an androgen-secreting tumour, as it helps differentiate between various causes of elevated androgen levels.",
    "is_verified": 1
  },
  {
    "question": "What are the recommendations for determining laboratory normal values for androgen measurements in females?",
    "answer": "Laboratories involved in androgen measurements in females should consider determining laboratory normal values by either the range of values in a well characterized healthy control population or by cluster analysis of the values of a large general population. They should also apply the most accurate methods available and use extraction/chromatography immunoassays as an alternative to mass spectrometry only where adequate expertise is available. Future improvements may arise from measurement of 11-oxygenated androgens and from establishing cut-off levels or thresholds based on large-scale validation in populations of different ages and ethnicities.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of hirsutism in relation to biochemical hyperandrogenism and PCOS?",
    "answer": "The presence of hirsutism alone should be considered predictive of biochemical hyperandrogenism and PCOS in adults.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professionals recognize about female pattern hair loss and acne in relation to biochemical hyperandrogenism?",
    "answer": "Healthcare professionals should recognize that female pattern hair loss and acne in isolation (without hirsutism) are relatively weak predictors of biochemical hyperandrogenism.",
    "is_verified": 1
  },
  {
    "question": "What is recommended for assessing clinical hyperandrogenism?",
    "answer": "A comprehensive history and physical examination should be completed for symptoms and signs of clinical hyperandrogenism, including acne, female pattern hair loss, and hirsutism in adults, and severe acne and hirsutism in adolescents.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professionals be aware of regarding the psychosocial impact of clinical hyperandrogenism?",
    "answer": "Healthcare professionals should be aware of the potential negative psychosocial impact of clinical hyperandrogenism and should consider this in their assessments and treatment plans.",
    "is_verified": 1
  },
  {
    "question": "What is the modified Ferriman Gallwey score (mFG) used for?",
    "answer": "The modified Ferriman Gallwey score (mFG) of 4–6 should be used to detect hirsutism, depending on ethnicity.",
    "is_verified": 1
  },
  {
    "question": "How does ethnicity affect the severity of hirsutism?",
    "answer": "Healthcare professionals should consider that the severity of hirsutism may vary by ethnicity, but the prevalence of hirsutism appears similar across ethnicities.",
    "is_verified": 1
  },
  {
    "question": "What visual scales are preferred for assessing hirsutism?",
    "answer": "Standardized visual scales, such as the mFG scale in combination with a photographic atlas, are preferred when assessing hirsutism.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professionals note about self-treatment of hirsutism?",
    "answer": "Healthcare professionals should recognize that women commonly treat clinical hyperandrogenism cosmetically, which can diminish their apparent clinical severity.",
    "is_verified": 1
  },
  {
    "question": "What is important to consider when assessing hirsutism?",
    "answer": "Only terminal hairs need to be considered in defining hirsutism, which can reach over 5 mm if untreated, vary in shape and texture, and are generally pigmented.",
    "is_verified": 1
  },
  {
    "question": "What should be investigated in cases of new-onset severe hyperandrogenism?",
    "answer": "New-onset severe or worsening hyperandrogenism, including hirsutism, requires further investigation to rule out androgen-secreting tumors and ovarian hyperthecosis.",
    "is_verified": 1
  },
  {
    "question": "What clinical signs should be monitored during therapy for hyperandrogenism?",
    "answer": "Clinical signs of hyperandrogenism, including hirsutism, acne, and female pattern hair loss, should be monitored for improvement or treatment adjustment during therapy.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of follicle number per ovary (FNPO) in relation to polycystic ovarian morphology?",
    "answer": "Follicle number per ovary (FNPO) should be considered the most effective measure in relation to polycystic ovarian morphology.",
    "is_verified": 1
  },
  {
    "question": "What are the ultrasound markers for detecting polycystic ovarian morphology (PCOM) in adults?",
    "answer": "The ultrasound markers for detecting polycystic ovarian morphology (PCOM) in adults include follicle number per ovary (FNPO), follicle number per cross-section (FNPS), and ovarian volume (OV).",
    "is_verified": 1
  },
  {
    "question": "What criteria should be used to diagnose PCOM?",
    "answer": "The criteria for diagnosing polycystic ovarian morphology (PCOM) should be based on follicle excess, which can be assessed through follicle number per ovary (FNPO), follicle number per cross-section (FNPS), and/or ovarian enlargement.",
    "is_verified": 1
  },
  {
    "question": "What is the threshold for polycystic ovary morphology (PCOM) in adults based on follicle number per ovary?",
    "answer": "20 in at least one ovary should be considered the threshold for PCOM in adults.",
    "is_verified": 1
  },
  {
    "question": "What ovarian volume is considered the threshold for PCOM in adults using older technology?",
    "answer": "10 ml or follicle number per section (FNPS) of 10 in at least one ovary should be considered the threshold for PCOM if using older technology or image quality is insufficient.",
    "is_verified": 1
  },
  {
    "question": "Why is ultrasound not recommended for diagnosing polycystic ovary morphology (PCOM) in adolescents?",
    "answer": "There are no definitive criteria to define polycystic ovary morphology (PCOM) on ultrasound in adolescents, hence it is not recommended in adolescents.",
    "is_verified": 1
  },
  {
    "question": "What is the most accurate approach for ultrasound diagnosis of PCOM when indicated?",
    "answer": "The transvaginal approach is the most accurate for the diagnosis of PCOM if acceptable to the individual.",
    "is_verified": 1
  },
  {
    "question": "What should transabdominal ultrasound primarily report regarding ovarian volume?",
    "answer": "Transabdominal ultrasound should primarily report ovarian volume (OV) with a threshold of 10 ml or follicle number per section (FNPS) of 10 in either ovary in adults.",
    "is_verified": 1
  },
  {
    "question": "Is an ovarian ultrasound necessary for diagnosing PCOS in patients with irregular menstrual cycles and hyperandrogenism?",
    "answer": "An ovarian ultrasound is not necessary for PCOS diagnosis in patients with irregular menstrual cycles and hyperandrogenism.",
    "is_verified": 1
  },
  {
    "question": "What is recommended for PCOM reporting on ultrasound?",
    "answer": "There is a need for training in careful and meticulous follicle counting per ovary and clear standardized protocols are recommended for PCOM reporting on ultrasound, including details such as last menstrual period, transducer bandwidth frequency, approach assessed, total number of 2–9 mm follicles per ovary, measurements in three dimensions or volume of each ovary, and other ovarian features or pathology.",
    "is_verified": 1
  },
  {
    "question": "What is the role of serum anti-Müllerian hormone (AMH) in diagnosing PCOS?",
    "answer": "Serum anti-Müllerian hormone (AMH) could be used for defining polycystic ovarian morphology (PCOM) in adults. However, it should not be used as a single test for the diagnosis of PCOS and should only be used in accordance with a diagnostic algorithm. In patients with irregular menstrual cycles and hyperandrogenism, an AMH level is not necessary for PCOS diagnosis. Additionally, serum AMH should not be used in adolescents.",
    "is_verified": 1
  },
  {
    "question": "What factors influence serum AMH levels in the general population?",
    "answer": "Factors that influence serum AMH levels include age (peaking between 20-25 years), body mass index (BMI, with lower levels in those with higher BMI), hormonal contraception (current or recent use of combined oral contraceptive pills may suppress AMH), and the menstrual cycle day (AMH levels may vary across the menstrual cycle).",
    "is_verified": 1
  },
  {
    "question": "What is the prevalence of PCOS across different ethnicities?",
    "answer": "PCOS prevalence is high across all ethnicities and world regions, estimated to be between 10-13% globally using the Rotterdam criteria. It may be higher in South East Asian and Eastern Mediterranean regions.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professionals be aware of regarding PCOS?",
    "answer": "Healthcare professionals should be aware that the presentation of Polycystic Ovary Syndrome (PCOS) may vary across ethnic groups.",
    "is_verified": 1
  },
  {
    "question": "What is mentioned about the menopause life stage in the excerpt?",
    "answer": "The excerpt references the menopause life stage but does not provide specific details about it.",
    "is_verified": 1
  },
  {
    "question": "What is the nature of PCOS according to the excerpt?",
    "answer": "A diagnosis of PCOS could be considered as enduring/lifelong.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professionals consider regarding hyperandrogenism in postmenopausal women with PCOS?",
    "answer": "Healthcare professionals could consider that both clinical and biochemical hyperandrogenism persist in the postmenopause for women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "Under what conditions can a PCOS diagnosis be considered postmenopause?",
    "answer": "PCOS diagnosis could be considered postmenopause if there is a past diagnosis, or a long-term history of oligo-amenorrhoea with hyperandrogenism and/or PCOM, during the earlier reproductive years (age 20-40).",
    "is_verified": 1
  },
  {
    "question": "What further investigations should be considered for postmenopausal women with new-onset hyperandrogenism?",
    "answer": "Further investigations should be considered to rule out androgen-secreting tumours and ovarian hyperthecosis in postmenopausal women presenting with new-onset, severe or worsening hyperandrogenism including hirsutism.",
    "is_verified": 1
  },
  {
    "question": "What is the cardiovascular disease risk for women with PCOS?",
    "answer": "Women with PCOS should be considered at increased risk of cardiovascular disease and potentially of cardiovascular mortality, acknowledging that the overall risk of cardiovascular disease in pre-menopausal women is low.",
    "is_verified": 1
  },
  {
    "question": "What assessments should be made for women with PCOS regarding cardiovascular disease?",
    "answer": "All women with PCOS should be assessed for cardiovascular disease risk factors.",
    "is_verified": 1
  },
  {
    "question": "What should be included in the lipid profile assessment for women with PCOS?",
    "answer": "All women with PCOS, regardless of age and BMI, should have a lipid profile (cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol and triglyceride level) at diagnosis. Thereafter, frequency of measurement should be based on the presence of hyperlipidaemia and additional risk factors or global cardiovascular risk.",
    "is_verified": 1
  },
  {
    "question": "What annual health measure should all women with PCOS have?",
    "answer": "All women with PCOS should have blood pressure measured annually and when planning pregnancy or seeking fertility treatment, given the high risk of hypertensive disorders in pregnancy and the associated comorbidities.",
    "is_verified": 1
  },
  {
    "question": "What should funding bodies recognize about PCOS?",
    "answer": "Funding bodies should recognize that PCOS is highly prevalent with multisystem effects including cardiometabolic disease and should diversify and increase research support accordingly.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between PCOS and cardiovascular risk?",
    "answer": "PCOS (Polycystic Ovary Syndrome) is considered a cardiovascular risk factor, and healthcare professionals, women with PCOS, and other stakeholders should prioritize preventative strategies to reduce cardiovascular risk.",
    "is_verified": 1
  },
  {
    "question": "What is the risk of impaired glucose tolerance and type 2 diabetes in women with PCOS?",
    "answer": "Women with PCOS have an increased risk of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes, regardless of age and BMI.",
    "is_verified": 1
  },
  {
    "question": "How often should glycaemic status be assessed in individuals with PCOS?",
    "answer": "Glycaemic status should be assessed at diagnosis in all adults and adolescents with PCOS and reassessed every one to three years based on additional individual risk factors for diabetes.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professionals and women with PCOS prioritize to reduce diabetes risk?",
    "answer": "They should prioritize preventative strategies to reduce type 2 diabetes risk, recognizing that PCOS is highly prevalent and has a significantly higher risk for diabetes.",
    "is_verified": 1
  },
  {
    "question": "Should diabetes guidelines consider PCOS as a risk factor?",
    "answer": "Yes, diabetes general population guidelines should consider the inclusion of PCOS as an independent risk factor for diabetes.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation for glycaemic testing in women with PCOS?",
    "answer": "Healthcare professionals and women with PCOS should recommend the 75-g glycaemic testing to assess glucose tolerance.",
    "is_verified": 1
  },
  {
    "question": "What should be recognized by funding bodies regarding PCOS?",
    "answer": "Funding bodies should recognize that PCOS is highly prevalent and has a significantly higher risk for diabetes, and should be funded accordingly.",
    "is_verified": 1
  },
  {
    "question": "What is the increased risk of diabetes for women with type 1 and type 2 diabetes?",
    "answer": "Women with type 1 and type 2 diabetes have an increased risk of PCOS, and screening should be considered in individuals with diabetes.",
    "is_verified": 1
  },
  {
    "question": "What is the oral glucose tolerance test (OGTT)?",
    "answer": "The oral glucose tolerance test (OGTT) is a medical test used to assess glycaemic status, particularly in conditions like polycystic ovary syndrome (PCOS). It is considered the most accurate test for this purpose, regardless of the patient's body mass index (BMI).",
    "is_verified": 1
  },
  {
    "question": "What alternatives are there to the OGTT if it cannot be performed?",
    "answer": "If an OGTT cannot be performed, alternatives include measuring fasting plasma glucose and/or glycated haemoglobin (HbA1c). However, these alternatives have significantly reduced accuracy compared to the OGTT.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation regarding OGTT for women with PCOS?",
    "answer": "An OGTT (Oral Glucose Tolerance Test) should be considered in all women with PCOS and without pre-existing diabetes when planning pregnancy or seeking fertility treatment due to the high risk of hyperglycaemia and associated comorbidities in pregnancy. If not performed preconception, it could be offered at the first prenatal visit and all women with PCOS should be offered the test at 24-28 weeks gestation.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between PCOS and insulin resistance?",
    "answer": "Insulin resistance is a pathophysiological factor in PCOS; however, clinically available insulin assays are of limited clinical relevance and are not recommended in routine care.",
    "is_verified": 1
  },
  {
    "question": "What is the prevalence of obstructive sleep apnea in women with PCOS?",
    "answer": "Women with PCOS have a significantly higher prevalence of obstructive sleep apnea compared to women without PCOS, independent of BMI.",
    "is_verified": 1
  },
  {
    "question": "What symptoms should be assessed in women with PCOS for obstructive sleep apnea?",
    "answer": "Women with PCOS should be assessed for symptoms of obstructive sleep apnea, which include snoring in combination with waking unrefreshed from sleep, daytime sleepiness, or fatigue. If these symptoms are present, screening with validated tools or referral for assessment is recommended.",
    "is_verified": 1
  },
  {
    "question": "What tools can assist in identifying obstructive sleep apnea in women with PCOS?",
    "answer": "Simple obstructive sleep apnea screening questionnaires, such as the Berlin questionnaire, can assist in identifying obstructive sleep apnea in women with PCOS, noting that a formal sleep study is required for diagnosis.",
    "is_verified": 1
  },
  {
    "question": "What is the risk of endometrial hyperplasia and cancer in women with PCOS?",
    "answer": "Premenopausal women with PCOS have a markedly higher risk of developing endometrial hyperplasia and endometrial cancer. Women with PCOS should be informed about this increased risk, although the overall chance of developing endometrial cancer is low.",
    "is_verified": 1
  },
  {
    "question": "What are the risk factors for endometrial hyperplasia and endometrial cancer associated with PCOS?",
    "answer": "Long-standing untreated amenorrhea, higher weight, type 2 diabetes, and persistent thickened endometrium are additional risk factors for endometrial hyperplasia and endometrial cancer associated with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What preventative strategies should women with PCOS be informed about?",
    "answer": "Women with PCOS should be informed of preventative strategies including weight management, cycle regulation, and regular progestogen therapy.",
    "is_verified": 1
  },
  {
    "question": "What is indicated when excessive endometrial thickness is detected in women with PCOS?",
    "answer": "When excessive endometrial thickness is detected, consideration of a biopsy with histological analysis and withdrawal bleed is indicated.",
    "is_verified": 1
  },
  {
    "question": "What increased health risks may fathers and brothers of women with PCOS face?",
    "answer": "Fathers and brothers of women with PCOS may have an increased prevalence of metabolic syndrome, type 2 diabetes, and hypertension.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professionals be aware of regarding psychological features in women with PCOS?",
    "answer": "Healthcare professionals should be aware that psychological features are a common and important component of PCOS and that women with PCOS have a significantly higher prevalence of psychological disorders.",
    "is_verified": 1
  },
  {
    "question": "What should be done regarding depression in adults and adolescents with PCOS?",
    "answer": "Healthcare professionals should screen for depression in all adults and adolescents with PCOS, using regionally validated screening tools, due to the high prevalence of moderate to severe depressive symptoms and depression in this population.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professionals be aware of regarding anxiety in adults with PCOS?",
    "answer": "Healthcare professionals should be aware of the high prevalence of moderate to severe anxiety symptoms and anxiety disorders in adults and should screen for anxiety in all adults with PCOS, using regionally validated screening tools.",
    "is_verified": 1
  },
  {
    "question": "What actions should practitioners take if moderate or severe depressive or anxiety symptoms are detected in patients?",
    "answer": "If moderate or severe depressive or anxiety symptoms are detected, practitioners should further assess, refer appropriately, or offer treatment.",
    "is_verified": 1
  },
  {
    "question": "What factors should healthcare professionals consider that can influence psychosexual function in PCOS?",
    "answer": "Healthcare professionals could consider multiple factors that can influence psychosexual function in PCOS, including higher weight, hirsutism, mood disorders, infertility, and PCOS medications.",
    "is_verified": 1
  },
  {
    "question": "What impact can features of PCOS have on body image?",
    "answer": "Healthcare professionals should be aware that features of PCOS can have a negative impact on body image.",
    "is_verified": 1
  },
  {
    "question": "What should be considered regarding eating disorders in patients with PCOS?",
    "answer": "Eating disorders and disordered eating should be considered in PCOS, regardless of weight, especially in the context of weight management and lifestyle interventions.",
    "is_verified": 1
  },
  {
    "question": "What should practitioners do if disordered eating or eating disorders are suspected in patients with PCOS?",
    "answer": "If disordered eating or eating disorders are suspected, appropriately qualified practitioners should further assess via a full diagnostic interview.",
    "is_verified": 1
  },
  {
    "question": "What should be offered if an eating disorder or disordered eating is detected?",
    "answer": "Appropriate management and support should be offered.",
    "is_verified": 1
  },
  {
    "question": "What type of information should be provided to individuals with PCOS?",
    "answer": "Tailored information, education, and resources that are high-quality, culturally appropriate, and inclusive should be provided to all with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What is a high priority for patients with PCOS?",
    "answer": "Information, education, and resources are a high priority for patients with PCOS and should be provided in a respectful and empathic manner.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professional education ensure regarding PCOS?",
    "answer": "Entities responsible for healthcare professional education should ensure that information and education on PCOS is systemically embedded at all levels of healthcare professional training to address knowledge gaps.",
    "is_verified": 1
  },
  {
    "question": "What should models of care prioritize for patients with PCOS?",
    "answer": "Models of care should prioritize equitable access to evidence-based primary care with pathways for escalation to integrated specialist and multidisciplinary services as required.",
    "is_verified": 1
  },
  {
    "question": "What should public health actors consider regarding PCOS?",
    "answer": "Public health actors should consider increasing societal awareness and education on PCOS to reduce stigma and marginalization.",
    "is_verified": 1
  },
  {
    "question": "What type of resources should be considered for families of those with PCOS?",
    "answer": "Culturally appropriate resources and education on PCOS across the life span for families of those with the condition should be considered.",
    "is_verified": 1
  },
  {
    "question": "What is the importance of being knowledgeable about PCOS?",
    "answer": "Healthcare professionals should recognize the importance of being knowledgeable about PCOS, applying evidence-based practices when sharing news on diagnosis, treatment, and health implications, and focusing on patient priorities.",
    "is_verified": 1
  },
  {
    "question": "What psychological therapies should be offered to women with PCOS diagnosed with depression or anxiety?",
    "answer": "Women with PCOS diagnosed with depression, anxiety, and/or eating disorders should be offered psychological therapy guided by regional general population guidelines and the preference of the woman with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What treatments should be offered to women with PCOS experiencing disordered eating or body image distress?",
    "answer": "Women with PCOS with disordered eating, body image distress, low self-esteem, problems with feminine identity, or psychosexual dysfunction should be offered evidence-based treatments such as cognitive behaviour therapy where appropriate.",
    "is_verified": 1
  },
  {
    "question": "What is the recommended first-line management for psychological issues in women with PCOS?",
    "answer": "Psychological therapy could be considered first-line management for women with PCOS experiencing psychological issues.",
    "is_verified": 1
  },
  {
    "question": "What are the considerations for antidepressant medications in adults with mental health disorders?",
    "answer": "Antidepressant medications should be considered in adults where mental health disorders are clearly documented and persistent, or if suicidal symptoms are present, based on general population guidelines. Healthcare professionals should apply caution to avoid inappropriate treatment with antidepressants or anxiolytics and limit the use of agents that exacerbate PCOS symptoms, including weight gain.",
    "is_verified": 1
  },
  {
    "question": "What lifestyle interventions are recommended for women with PCOS?",
    "answer": "Lifestyle interventions such as exercise alone or a multicomponent diet combined with exercise and behavioral strategies should be recommended for all women with PCOS to improve metabolic health, including central adiposity and lipid profile. Healthy lifestyle behaviors encompassing healthy eating and physical activity should also be recommended to optimize general health, quality of life, body composition, and weight management.",
    "is_verified": 1
  },
  {
    "question": "What is the impact of not managing anxiety and depression in PCOS treatment?",
    "answer": "Healthcare professionals should be aware that not managing anxiety and depression may impact adherence to PCOS treatment and management.",
    "is_verified": 1
  },
  {
    "question": "What are the key points to consider for weight management in individuals with higher weight?",
    "answer": "1. A lifelong focus on prevention of further weight gain. 2. If the goal is to achieve weight loss, a tailored energy deficit could be prescribed for women, considering individual energy requirements, body weight, and physical activity levels. 3. The value of improvement in central adiposity (e.g., waist circumference, waist-hip ratio) or metabolic health. 4. The need for ongoing assessment and support.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professionals be aware of when discussing lifestyle management with women with PCOS?",
    "answer": "Healthcare professionals should be aware of weight stigma when discussing lifestyle management with women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between insulin resistance and PCOS?",
    "answer": "Insulin resistance is a pathophysiological factor in PCOS; however, clinically available insulin assays are of limited clinical relevance and should not be used in routine care.",
    "is_verified": 1
  },
  {
    "question": "What lifestyle interventions could optimize weight management and emotional wellbeing in women with PCOS?",
    "answer": "Lifestyle interventions could include behavioral strategies such as goal-setting, self-monitoring, problem solving, assertiveness training, reinforcing changes, and relapse prevention.",
    "is_verified": 1
  },
  {
    "question": "What type of support could be included in behavioral strategies for weight management in women with PCOS?",
    "answer": "Behavioral support could include goal-setting, problem solving, self-monitoring and reviewing, or SMART goals (Specific, Measurable, Achievable, Realistic and Timely).",
    "is_verified": 1
  },
  {
    "question": "What type of interventions could be considered to increase support and engagement in women with PCOS?",
    "answer": "Comprehensive healthy behavioral or cognitive behavioral interventions could be considered to increase support, engagement, and retention.",
    "is_verified": 1
  },
  {
    "question": "What dietary interventions are recommended for women with PCOS?",
    "answer": "Healthcare professionals and women should consider that there is no evidence to support any one type of diet composition over another for anthropometric, metabolic, hormonal, reproductive, or psychological outcomes. Any diet composition consistent with population guidelines for healthy eating will have health benefits. Tailoring dietary changes to food preferences and avoiding restrictive diets is important. Barriers and facilitators to dietary change should be discussed, and referral to trained allied healthcare professionals may be necessary for support.",
    "is_verified": 1
  },
  {
    "question": "What exercise interventions are suggested for women with PCOS?",
    "answer": "Healthcare professionals and women could consider that there is a lack of evidence supporting any one type and intensity of exercise being better than another for anthropometric, metabolic, hormonal, reproductive, or psychological outcomes. Any physical activity consistent with population guidelines will have health benefits, and sustainable physical activity should be advised based on individual preferences and goals.",
    "is_verified": 1
  },
  {
    "question": "What are the recommendations for physical activity for adults according to the excerpt?",
    "answer": "Adults should aim for a minimum of 150 to 300 minutes of moderate intensity activities or 75 to 150 minutes of vigorous intensity aerobic activity per week, plus muscle strengthening activities on two non-consecutive days per week. For greater health benefits, adults should aim for a minimum of 250 minutes per week of moderate intensity activities or 150 minutes per week of vigorous intensities, along with muscle strengthening activities ideally on two non-consecutive days per week.",
    "is_verified": 1
  },
  {
    "question": "What is the recommended physical activity for adolescents?",
    "answer": "Adolescents should aim for at least 60 minutes of moderate- to vigorous-intensity physical activity per day, including activities that strengthen muscle and bone at least three times per week.",
    "is_verified": 1
  },
  {
    "question": "What is the definition of physical activity as per the excerpt?",
    "answer": "Physical activity is any bodily movement produced by skeletal muscles that requires energy expenditure, including leisure time physical activity, transportation, occupational work, household chores, playing games, sports, or planned exercise, as well as activities in daily, family, and community contexts.",
    "is_verified": 1
  },
  {
    "question": "What is the minimum duration for aerobic activity as mentioned in the excerpt?",
    "answer": "Aerobic activity is best performed in bouts of at least 10 minutes duration.",
    "is_verified": 1
  },
  {
    "question": "What are the psychological factors affecting physical activity in women with PCOS?",
    "answer": "Psychological factors include body image concerns, fear of injury, fear of failure, and mental health issues.",
    "is_verified": 1
  },
  {
    "question": "What is the role of healthcare professionals in managing physical activity for women with PCOS?",
    "answer": "Healthcare professionals should refer women with PCOS to suitably trained allied healthcare professionals to optimize physical activity.",
    "is_verified": 1
  },
  {
    "question": "What are the challenges faced by women with PCOS regarding weight management?",
    "answer": "Women with PCOS may have underlying mechanisms that drive greater longitudinal weight gain and higher BMI, leading to greater challenges with weight management.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of lifelong healthy lifestyle strategies for women with PCOS?",
    "answer": "Lifelong healthy lifestyle strategies are important for the prevention of excess weight gain and assist women with PCOS in forming realistic, tailored lifestyle goals.",
    "is_verified": 1
  },
  {
    "question": "How does weight stigma affect women with PCOS?",
    "answer": "Many women with PCOS experience weight stigma in healthcare and other settings, which has negative biopsychosocial impacts that should be recognized.",
    "is_verified": 1
  },
  {
    "question": "What should healthcare professionals be aware of regarding their biases?",
    "answer": "Healthcare professionals should be aware of their weight biases and the impact this has on their professional practice and on women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What should health policy makers promote regarding weight stigma?",
    "answer": "Health policy makers, managers, and educators should promote awareness of weight stigma and invest in weight stigma education and minimization strategies.",
    "is_verified": 1
  },
  {
    "question": "What are the recommendations for healthcare professionals regarding weight and PCOS?",
    "answer": "Healthcare professionals should be aware of weight-inclusive practices that promote acceptance of body size diversity and focus on health behaviors and outcomes for individuals of all sizes. Specifically for PCOS, recommendations include acknowledging that higher weight is a risk factor but only one indicator of health, asking permission to discuss weight, minimizing discomfort during weighing, recognizing the stigmatizing nature of terms like 'overweight' and 'obese', explaining the use of weight information in treatment, ensuring appropriate equipment for all sizes, offering tailored care options, and providing best practice assessment and treatment regardless of weight.",
    "is_verified": 1
  },
  {
    "question": "What pharmacological treatment principles should be considered in PCOS management?",
    "answer": "Pharmacological treatment principles in PCOS management include shared decision making between the patient and healthcare professional, considering the individual’s characteristics, preferences, and values when recommending interventions, and understanding how individuals value treatment options.",
    "is_verified": 1
  },
  {
    "question": "What is the role of combined oral contraceptive pills (COCP) in managing PCOS?",
    "answer": "Combined oral contraceptive pills (COCP) could be recommended in reproductive age adults with PCOS for management of hirsutism and/or irregular menstrual cycles. They could also be considered in adolescents at risk or with a clear diagnosis of PCOS for the same management purposes.",
    "is_verified": 1
  },
  {
    "question": "Is there a clinical advantage of using high dose ethinylestradiol versus low dose when treating hirsutism in adults with PCOS?",
    "answer": "Healthcare professionals could consider that there is no clinical advantage of using high dose ethinylestradiol (R 30 mg) versus low dose ethinylestradiol (< 30mg) when treating hirsutism in adults with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What should be considered when prescribing COCP in adults and adolescents with PCOS?",
    "answer": "General population guidelines should be considered when prescribing COCP in adults and adolescents with PCOS as specific types or doses of progestins, estrogens or combinations of COCP cannot currently be recommended.",
    "is_verified": 1
  },
  {
    "question": "What is recommended as second-line therapy for PCOS?",
    "answer": "The 35 mg ethinyl estradiol plus cyproterone acetate preparations should be considered as second-line therapy over other COCPs, balancing benefits and adverse effects, including venous thromboembolic risks.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation for progestin only oral contraceptives in women with PCOS?",
    "answer": "Progestin only oral contraceptives may be considered for endometrial protection, based on general population guidelines, acknowledging that evidence in women with PCOS is limited.",
    "is_verified": 1
  },
  {
    "question": "What are the considerations when prescribing COCPs for adults and adolescents with PCOS?",
    "answer": "When prescribing COCPs (Combined Oral Contraceptive Pills) for adults and adolescents with PCOS, it is important to address the main presenting symptoms and consider other treatments such as cosmetic therapies. Shared decision-making is recommended, including providing accurate information and reassurance on the efficacy and safety of COCPs to improve adherence. Natural estrogen preparations and the lowest effective estrogen doses (such as 20-30mg of ethinyl estradiol or equivalent) should be considered, balancing efficacy, metabolic risk profile, side effects, cost, and availability. The limited evidence on COCPs specifically in PCOS should be acknowledged, and practice should be informed by general population guidelines. Additionally, the relative and absolute contraindications and side effects of COCPs need to be considered and discussed individually. PCOS-specific features, such as higher weight and cardiovascular risk factors, should also be taken into account.",
    "is_verified": 1
  },
  {
    "question": "What is the role of Metformin in the treatment of PCOS?",
    "answer": "Metformin should be considered in adults with PCOS who have a BMI of 25 kg/m2 or higher for improving anthropometric and metabolic outcomes, including insulin resistance, glucose, and lipid profiles. It could also be considered in adolescents at risk of or with PCOS for cycle regulation, although there is limited evidence. For adults with PCOS and a BMI less than 25 kg/m2, Metformin may still be considered, again acknowledging the limited evidence. When prescribing Metformin, shared decision-making should include considerations of the feasibility and effectiveness of active lifestyle interventions, as women should be informed that Metformin and active lifestyle interventions have similar efficacy. Mild adverse effects, particularly gastrointestinal side effects, are generally dose-dependent and self-limiting, and it is recommended to start at a low dose with increments of 500mg every 1-2 weeks.",
    "is_verified": 1
  },
  {
    "question": "What is the suggested maximum daily dose of a certain medication for adults and adolescents?",
    "answer": "The suggested maximum daily dose is 2.5g in adults and 2g in adolescents.",
    "is_verified": 1
  },
  {
    "question": "What are the potential risks associated with the use of the medication mentioned in the excerpt?",
    "answer": "Use may be associated with low vitamin B12 levels, especially in those with risk factors for low vitamin B12 such as diabetes, post bariatric/metabolic surgery, pernicious anaemia, and a vegan diet, where monitoring should be considered.",
    "is_verified": 1
  },
  {
    "question": "What are the recommendations for the use of metformin in relation to combined oral contraceptive pills (COCP) for managing PCOS?",
    "answer": "Metformin could be used over COCP for metabolic indications in PCOS, and in combination with COCP, metformin may be most beneficial in high metabolic risk groups including those with a BMI > 30 kg/m2, diabetes risk factors, impaired glucose tolerance, or high-risk ethnic groups. Where COCP is contraindicated, not accepted, or not tolerated, metformin may be considered for irregular menstrual cycles.",
    "is_verified": 1
  },
  {
    "question": "What anti-obesity medications are mentioned for the management of higher weight in adults with PCOS?",
    "answer": "Anti-obesity medications including liraglutide, semaglutide (both glucagon-like peptide-1 (GLP-1) receptor agonists), and orlistat could be considered, in addition to active lifestyle intervention, for the management of higher weight in adults with PCOS as per general population guidelines.",
    "is_verified": 1
  },
  {
    "question": "What precaution should healthcare professionals take when prescribing GLP-1 receptor agonists to women?",
    "answer": "Healthcare professionals should ensure concurrent effective contraception when pregnancy is possible for women who take GLP-1 receptor agonists, as pregnancy safety data are lacking.",
    "is_verified": 1
  },
  {
    "question": "What is recommended to reduce gastrointestinal adverse effects when using GLP-1 receptor agonists?",
    "answer": "Gradual dose escalation for GLP-1 receptor agonists is recommended to reduce gastrointestinal adverse effects.",
    "is_verified": 1
  },
  {
    "question": "What considerations should be made when discussing GLP-1 receptor agonist use with women with PCOS?",
    "answer": "Shared decision making needs to consider side effects, the potential need for long-term use in weight management, the high risk for weight regain after discontinuation, and the lack of long-term safety data.",
    "is_verified": 1
  },
  {
    "question": "What type of pharmacological agents are mentioned in the excerpt?",
    "answer": "Anti-androgen pharmacological agents are mentioned in the excerpt.",
    "is_verified": 1
  },
  {
    "question": "What are anti-androgens used for in women with PCOS?",
    "answer": "Anti-androgens could be considered to treat hirsutism in women with PCOS, especially if there is a suboptimal response after a minimum of six months of combined oral contraceptive pill (COCP) therapy and/or cosmetic therapy.",
    "is_verified": 1
  },
  {
    "question": "What precautions should be taken when using anti-androgens in women who can become pregnant?",
    "answer": "Healthcare professionals must educate and counsel women and adolescents regarding the risks of incomplete development of external genital structures of male fetuses (undervirilization) when anti-androgens are used. Women who can get pregnant should be strongly counselled to use effective contraception, such as intrauterine devices or COCPs, to prevent this risk.",
    "is_verified": 1
  },
  {
    "question": "What are the recommendations regarding the use of specific anti-androgens?",
    "answer": "When prescribing anti-androgens, healthcare professionals should consider the following: Spironolactone at 25-100mg/day appears to have lower risks of adverse effects; Cyproterone acetate at doses of 10mg or more is not advised due to an increased risk of meningioma; Finasteride has an increased risk of liver toxicity; Flutamide and bicalutamide have an increased risk of severe liver toxicity. Additionally, the limited evidence on anti-androgens in PCOS should be acknowledged due to small study sizes and participant numbers.",
    "is_verified": 1
  },
  {
    "question": "What is the potential role of inositol in women with PCOS?",
    "answer": "Inositol (in any form) could be considered in women with PCOS based on individual preferences and values, noting limited harm and potential for improvement in metabolic measures, although it has limited clinical benefits regarding ovulation, hirsutism, or weight.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation regarding the use of Metformin for hirsutism and central adiposity?",
    "answer": "Metformin should be considered over inositol for hirsutism and central adiposity, although it has more gastrointestinal side effects than inositol.",
    "is_verified": 1
  },
  {
    "question": "What is the current recommendation for the use of inositol in adults and adolescents with PCOS?",
    "answer": "Specific types, doses, or combinations of inositol cannot currently be recommended in adults and adolescents with PCOS due to a lack of quality evidence.",
    "is_verified": 1
  },
  {
    "question": "What should women taking inositol and other complementary therapies do?",
    "answer": "Women taking inositol and other complementary therapies are encouraged to advise their healthcare professional.",
    "is_verified": 1
  },
  {
    "question": "What therapies are suggested for reducing facial hirsutism in women with PCOS?",
    "answer": "Mechanical laser and light therapies should be considered for reducing facial hirsutism and for related depression, anxiety, and quality of life in women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "How does the number of laser treatment sessions compare between women with PCOS and those with idiopathic hirsutism?",
    "answer": "A greater number of laser treatment sessions may be required in women with PCOS compared to women with idiopathic hirsutism to achieve hair reduction.",
    "is_verified": 1
  },
  {
    "question": "What should be considered when prescribing laser hair removal?",
    "answer": "When laser hair removal is prescribed, the wavelength and delivery of laser treatment should vary by skin and hair color, and it is relatively ineffective in women with blond, grey, or white hair.",
    "is_verified": 1
  },
  {
    "question": "What is the safety of adverse effects related to laser hair reduction therapies?",
    "answer": "Adverse effects appear limited in the hands of experienced and suitably qualified providers, and women should be encouraged to seek hair reduction therapies from such providers.",
    "is_verified": 1
  },
  {
    "question": "What are combined oral contraceptive pills (COCP) used for in relation to hair reduction?",
    "answer": "Combined oral contraceptive pills (COCP), when added to laser treatment, may enhance hair reduction and maintenance compared to laser treatment alone. They can be used in conjunction with anti-androgens for better results.",
    "is_verified": 1
  },
  {
    "question": "What is the effect of low and high fluence laser on facial hair reduction?",
    "answer": "Both low and high fluence lasers have similar efficacy in reducing facial hair. However, low fluence laser treatment is associated with reduced pain during the procedure.",
    "is_verified": 1
  },
  {
    "question": "What is the role of mechanical hair removal with Intense Pulse Light (IPL) in treating hirsutism in women with PCOS?",
    "answer": "Mechanical hair removal with Intense Pulse Light (IPL) could be considered for treating hirsutism in women with PCOS, although the benefits may be less pronounced compared to laser treatment. There is no evidence supporting the efficacy of home-based IPL kits.",
    "is_verified": 1
  },
  {
    "question": "How can bariatric/metabolic surgery impact women with PCOS?",
    "answer": "Bariatric/metabolic surgery could be considered to improve weight loss, hypertension, diabetes (prevention and treatment), hirsutism, irregular menstrual cycles, ovulation, and pregnancy rates in women with PCOS. It should be informed by general population guidelines and may be indicated at a lower BMI threshold due to the metabolic nature of PCOS.",
    "is_verified": 1
  },
  {
    "question": "What counseling should women with PCOS receive regarding fertility and contraception prior to bariatric/metabolic surgery?",
    "answer": "Women with PCOS should be strongly counseled on the likelihood of rapid return of fertility after bariatric/metabolic surgery and the need to commit to effective contraception, ideally prior to surgery. Contraception should continue until a stable weight is achieved, usually after one year, to avoid increased risks during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What are the pregnancy risks associated with women who have PCOS?",
    "answer": "Women with PCOS have higher risk pregnancies, including higher gestational weight gain, miscarriage, and gestational diabetes. Healthcare professionals should ensure that PCOS status is identified during antenatal care and provide appropriate monitoring and support.",
    "is_verified": 1
  },
  {
    "question": "What are some medical conditions related to pregnancy mentioned in the excerpt?",
    "answer": "The excerpt mentions several medical conditions related to pregnancy including miscarriage, gestational diabetes, hypertension in pregnancy, preeclampsia, intrauterine growth restriction, small for gestational age babies, low birth weight, preterm delivery, and caesarean section.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation for women with PCOS regarding lifestyle intervention during pregnancy?",
    "answer": "Early lifestyle intervention should be offered to pregnant women with PCOS due to the risk of higher baseline weight, excess gestational weight gain, and pregnancy complications.",
    "is_verified": 1
  },
  {
    "question": "What should be performed when planning pregnancy or seeking fertility treatment for women with PCOS?",
    "answer": "Blood pressure measurement should be performed when planning pregnancy or seeking fertility treatment, given the high risk of hypertensive disorders in pregnancy and associated comorbidities in women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What screening is recommended for women with PCOS when planning pregnancy?",
    "answer": "An Oral Glucose Tolerance Test (OGTT) should be offered to all women with PCOS when planning pregnancy or seeking fertility treatment due to the high risk of hyperglycaemia and associated comorbidities in pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What does the excerpt say about the use of metformin in pregnant women with PCOS?",
    "answer": "The excerpt states that healthcare professionals should be aware that metformin in pregnant women with PCOS has not been shown to prevent gestational diabetes, late miscarriage, hypertension in pregnancy, pre-eclampsia, or macrosomia (birthweight of 4000 g or more).",
    "is_verified": 1
  },
  {
    "question": "What is the role of metformin in pregnant women with PCOS?",
    "answer": "Metformin could be considered in some circumstances, such as the risk for preterm birth, to reduce preterm delivery and limit excess gestational weight gain in pregnant women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What are the side effects of metformin during pregnancy?",
    "answer": "The side effects of metformin are mostly mild, transient gastrointestinal symptoms and are not worse in pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What should women with PCOS be counselled regarding fertility treatment?",
    "answer": "Women with PCOS should be reassured that pregnancy can often be successfully achieved either naturally or with assistance, and they should be counselled on the adverse impact of excess weight on clinical pregnancy, miscarriage, and live birth rates following infertility treatment.",
    "is_verified": 1
  },
  {
    "question": "What is the importance of prenatal vitamins in women with PCOS undergoing ovulation induction therapy?",
    "answer": "Prenatal vitamins supplementation should be commenced with ovulation induction therapy aligned to routine preconception care.",
    "is_verified": 1
  },
  {
    "question": "What should be monitored in patients using ovulation induction agents?",
    "answer": "There should be ongoing monitoring of patients for adverse effects and infants for congenital anomalies in all studies conducted with ovulation induction agents, and these should be reported in any published papers.",
    "is_verified": 1
  },
  {
    "question": "What preconception risk factors should women with PCOS be aware of?",
    "answer": "Women with PCOS should be counselled on the adverse impact of excess weight on clinical pregnancy, miscarriage, and live birth rates, and consistent with routine preconception care, they should consider factors such as weight, blood pressure, smoking, alcohol, diet, and nutritional status.",
    "is_verified": 1
  },
  {
    "question": "What is the recommended approach for managing reproductive health in adolescents and women with PCOS?",
    "answer": "A reproductive life plan and age-appropriate education on optimizing reproductive health is recommended, including healthy lifestyle choices, prevention of excess weight gain, and optimizing preconception risk factors.",
    "is_verified": 1
  },
  {
    "question": "What chronic conditions should be managed in women to reduce the risk of adverse pregnancy outcomes?",
    "answer": "Chronic conditions such as diabetes, high blood pressure, anxiety, depression, and other mental health conditions should be optimally managed, and women should be counselled regarding the risk of adverse pregnancy outcomes.",
    "is_verified": 1
  },
  {
    "question": "What is the first-line pharmacological treatment for ovulation induction in infertile anovulatory women with PCOS?",
    "answer": "Letrozole should be the first-line pharmacological treatment for ovulation induction in infertile anovulatory women with PCOS, provided there are no other infertility factors.",
    "is_verified": 1
  },
  {
    "question": "What should be considered before starting ovulation induction in women with PCOS and infertility?",
    "answer": "The risks, benefits, costs, timing, and techniques of tubal patency testing should be considered on an individual basis, depending on personal history and population prevalence, prior to starting ovulation induction with timed intercourse or intrauterine insemination.",
    "is_verified": 1
  },
  {
    "question": "What is teratogenicity?",
    "answer": "Teratogenicity refers to the capability of a substance to cause birth defects or developmental abnormalities in a fetus when a pregnant individual is exposed to it. In the context of the excerpt, it suggests that the ovulation induction agents mentioned do not show a higher risk of causing such defects compared to other similar agents.",
    "is_verified": 1
  },
  {
    "question": "What are ovulation induction agents?",
    "answer": "Ovulation induction agents are medications used to stimulate ovulation in individuals who have difficulty conceiving due to irregular or absent ovulation. These agents help to regulate hormonal levels and promote the release of eggs from the ovaries, increasing the chances of pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the use of metformin in women with PCOS?",
    "answer": "Metformin could be used alone in women with PCOS with anovulatory infertility and no other infertility factors to improve clinical pregnancy and live birth rates, while informing women that there are more effective ovulation agents.",
    "is_verified": 1
  },
  {
    "question": "What are the potential side effects of metformin?",
    "answer": "Women should be counselled about potential mild gastrointestinal side-effects with metformin.",
    "is_verified": 1
  },
  {
    "question": "What should be considered before prescribing metformin?",
    "answer": "Consideration of age and screening for other fertility factors needs to be discussed before prescribing metformin.",
    "is_verified": 1
  },
  {
    "question": "What is the risk associated with clomiphene citrate use?",
    "answer": "The risk of multiple pregnancy is increased with clomiphene citrate use (alone or in combination with metformin), and therefore clomiphene cycles may require ultrasound monitoring.",
    "is_verified": 1
  },
  {
    "question": "How does clomiphene citrate combined with metformin compare to clomiphene citrate alone?",
    "answer": "Clomiphene citrate combined with metformin could be used rather than clomiphene citrate alone in women with PCOS with anovulatory infertility and no other infertility factors to improve ovulation and clinical pregnancy rates.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation regarding Letrozole and clomiphene citrate?",
    "answer": "Letrozole should be used rather than clomiphene citrate in women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What is the role of gonadotrophins in treating anovulatory infertility in women with PCOS?",
    "answer": "Gonadotrophins alone could be considered as a treatment option for therapy naïve women with PCOS who have anovulatory infertility and no other infertility factors. They can also be used over gonadotrophins combined with clomiphene citrate in women with PCOS who are anovulatory and infertile, particularly in cases of clomiphene citrate resistance or failure. Additionally, gonadotrophins may be considered instead of the combination of clomiphene citrate and metformin for these patients. They can serve as a second-line pharmacological therapy for women who have failed first-line oral ovulation induction.",
    "is_verified": 1
  },
  {
    "question": "What are the considerations when prescribing gonadotrophins for ovulation induction?",
    "answer": "When prescribing gonadotrophins for ovulation induction, several factors should be considered: the cost of the intervention, the expertise required for its use, and the degree of intensive ultrasound monitoring that is necessary.",
    "is_verified": 1
  },
  {
    "question": "What does current evidence suggest about fetal abnormality rates between different ovulation induction methods?",
    "answer": "Current evidence demonstrates no difference in fetal abnormality rates between letrozole or clomiphene citrate ovulation induction and natural conception.",
    "is_verified": 1
  },
  {
    "question": "What are the potential outcomes of using gonadotrophins in women with PCOS who are anovulatory and infertile?",
    "answer": "Using gonadotrophins in women with PCOS who are anovulatory and infertile can lead to higher live birth rates, but it is important to counsel patients about the potential for higher multiple pregnancy rates associated with gonadotrophin use.",
    "is_verified": 1
  },
  {
    "question": "What is a low dose step-up gonadotrophin protocol?",
    "answer": "A low dose step-up gonadotrophin protocol is a fertility treatment approach that involves starting with a low dose of gonadotrophins (hormones that stimulate the ovaries) and gradually increasing the dose to optimize the chance of developing a single follicle (monofollicular development) during ovarian stimulation. This method aims to reduce the risk of multiple pregnancies while still effectively promoting ovulation.",
    "is_verified": 1
  },
  {
    "question": "What are gonadotrophins and their role in fertility treatment?",
    "answer": "Gonadotrophins are hormones produced by the pituitary gland that play a crucial role in regulating reproductive processes. In fertility treatments, they are used to stimulate the ovaries to produce eggs. Common gonadotrophin preparations include FSH (follicle-stimulating hormone) and LH (luteinizing hormone), which are administered to enhance ovarian response and improve the chances of conception.",
    "is_verified": 1
  },
  {
    "question": "What are the implications of potential multiple pregnancy in fertility treatments?",
    "answer": "The implications of potential multiple pregnancy in fertility treatments include increased risks for both the mother and the babies. Multiple pregnancies can lead to complications such as preterm birth, low birth weight, and higher rates of cesarean delivery. Therefore, fertility protocols often aim to minimize the chances of multiple pregnancies while still achieving successful outcomes.",
    "is_verified": 1
  },
  {
    "question": "Is there a difference in clinical efficacy among available gonadotrophin preparations?",
    "answer": "According to the excerpt, there appears to be no significant difference in the clinical efficacy of the available gonadotrophin preparations. This suggests that different formulations may be equally effective in stimulating ovarian function during fertility treatments.",
    "is_verified": 1
  },
  {
    "question": "What are the considerations when using gonadotrophins for fertility treatment?",
    "answer": "When using gonadotrophins, best clinical practice is to avoid multiple pregnancies. This includes cancelling cycles when there are more than two follicles greater than 14mm in diameter and advising avoidance of unprotected intercourse.",
    "is_verified": 1
  },
  {
    "question": "How do gonadotrophins compare to clomiphene citrate in terms of pregnancy rates?",
    "answer": "The live birth rate, clinical pregnancy rate per patient, and ovulation rate per cycle are higher with gonadotrophins than with clomiphene citrate.",
    "is_verified": 1
  },
  {
    "question": "What protocol should be used with gonadotrophins to minimize multiple pregnancies?",
    "answer": "A low dose gonadotrophin protocol should be used to optimize the chance of monofollicular growth and minimize multiple pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is laparoscopic ovarian surgery used for in women with PCOS?",
    "answer": "Laparoscopic ovarian surgery could be a second-line therapy for women with PCOS who are anovulatory and infertile, particularly those who are resistant to clomiphene citrate and have no other infertility factors.",
    "is_verified": 1
  },
  {
    "question": "What should be considered when using laparoscopic ovarian surgery for ovulation induction?",
    "answer": "Considerations include the comparative cost of the intervention, the expertise required for safe use, and both intraoperative and postoperative risks, which are higher in women above healthy weight.",
    "is_verified": 1
  },
  {
    "question": "When is in vitro fertilization (IVF) offered to women with PCOS?",
    "answer": "IVF could be offered to women with PCOS and anovulatory infertility if first- or second-line ovulation induction therapies have failed.",
    "is_verified": 1
  },
  {
    "question": "What is the effectiveness of IVF in women with anovulatory PCOS?",
    "answer": "In women with anovulatory PCOS, the use of IVF is effective, and when elective single embryo transfer is used, multiple pregnancies can be minimized.",
    "is_verified": 1
  },
  {
    "question": "What should women with PCOS be counseled about before starting IVF/ICSI treatment?",
    "answer": "Women with PCOS undergoing IVF/ICSI treatment should be counseled about the increased risk of ovarian hyperstimulation syndrome and offered options to reduce this risk.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation regarding the use of GnRH antagonist protocol for women with PCOS undergoing IVF/ICSI?",
    "answer": "The use of a GnRH antagonist protocol for women with PCOS undergoing IVF/ICSI is recommended as it enables the use of an agonist trigger, with the freezing of all embryos generated if required, without compromising the cumulative live birth rate, to reduce the risk of significant ovarian hyperstimulation syndrome.",
    "is_verified": 1
  },
  {
    "question": "What is the recommended trigger type in an IVF/ICSI cycle with a GnRH antagonist protocol?",
    "answer": "Triggering final oocyte maturation with a GnRH agonist and freezing all suitable embryos is recommended in an IVF/ICSI cycle with a GnRH antagonist protocol, where a fresh embryo transfer is not intended or where there is an increased risk of ovarian hyperstimulation syndrome.",
    "is_verified": 1
  },
  {
    "question": "What type of follicle stimulating hormone (FSH) can be used in women with PCOS undergoing IVF/ICSI?",
    "answer": "Either urinary or recombinant follicle stimulating hormone (FSH) could be used in women with PCOS undergoing controlled ovarian (hyper) stimulation for IVF/ICSI, with insufficient evidence to recommend a particular type of FSH preparation.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation regarding the use of exogenous luteinising hormone (LH) in women with PCOS undergoing IVF/ICSI?",
    "answer": "Exogenous recombinant luteinising hormone (LH) treatment should not be routinely used in combination with FSH therapy in women with PCOS undergoing controlled ovarian hyperstimulation for IVF/ICSI.",
    "is_verified": 1
  },
  {
    "question": "How can adjunct metformin therapy be beneficial for women with PCOS undergoing IVF/ICSI?",
    "answer": "Adjunct metformin therapy could be used before and/or during FSH ovarian stimulation in women with PCOS undergoing IVF/ICSI treatment with GnRH agonist long protocol, to reduce the risk of developing ovarian hyperstimulation syndrome and miscarriage.",
    "is_verified": 1
  },
  {
    "question": "What is the recommended approach for using metformin in conjunction with GnRH agonist treatment?",
    "answer": "Commence metformin at the start of GnRH agonist treatment and gradually titrate the dose up to between 1000mg to 2500mg daily to minimize side effects. It is advised to stop metformin therapy at the time of the pregnancy test or period, unless otherwise indicated.",
    "is_verified": 1
  },
  {
    "question": "What are the diagnostic steps for polycystic ovary syndrome (PCOS)?",
    "answer": "1. Step 1: Assess for irregular cycles and clinical hyperandrogenism, and exclude other causes to establish a diagnosis. 2. Step 2: If there is no clinical hyperandrogenism, test for biochemical hyperandrogenism and exclude other causes to establish a diagnosis. 3. Step 3: If there are only irregular cycles or hyperandrogenism, adolescents do not require an ultrasound but should be considered at risk for PCOS and reassessed later. For adults, an ultrasound should be requested for polycystic ovarian morphology (PCOM), and if positive, other causes must be excluded to confirm the diagnosis. Exclusion of other causes includes testing for TSH, prolactin, 17-OH progesterone, FSH, and conditions like Cushing's syndrome and adrenal tumors.",
    "is_verified": 1
  },
  {
    "question": "What tests are recommended for the exclusion of other causes in diagnosing PCOS?",
    "answer": "Tests recommended for the exclusion of other causes include TSH (thyroid stimulating hormone), prolactin, 17-OH progesterone, and FSH (follicle stimulating hormone). Additionally, conditions such as Cushing's syndrome and adrenal tumors should be considered and excluded clinically.",
    "is_verified": 1
  },
  {
    "question": "What is PCOM and its relevance in diagnosing PCOS in adults?",
    "answer": "PCOM stands for polycystic ovarian morphology, which is assessed through ultrasound. In adults, if PCOM is identified, it is relevant for diagnosing PCOS, and other causes must be excluded to confirm the diagnosis.",
    "is_verified": 1
  },
  {
    "question": "What is hypogonadotrophic hypogonadism and how is it assessed?",
    "answer": "Hypogonadotrophic hypogonadism is usually due to low body fat or intensive exercise. It is assessed clinically and through testing LH (luteinizing hormone) and FSH (follicle stimulating hormone) levels.",
    "is_verified": 1
  },
  {
    "question": "What reproductive technologies could be considered for women with PCOS according to the guidelines?",
    "answer": "The use of in vitro maturation (IVM) and intracytoplasmic sperm injection (ICSI) could be considered for women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of using IVM and ICSI in women with PCOS?",
    "answer": "IVM (In Vitro Maturation) and ICSI (Intracytoplasmic Sperm Injection) could be considered prior to stimulated IVF/ICSI cycles, acknowledging both benefits and limitations. IVM should only be considered in services with sufficient expertise, especially in women with prior severe ovarian hyperstimulation syndrome where the risk is deemed unacceptably high. However, evidence suggests that IVM/ICSI is less effective than standard IVF/ICSI in terms of clinical pregnancy and live birth rates.",
    "is_verified": 1
  },
  {
    "question": "What is the role of inositol in treating infertility in women with PCOS?",
    "answer": "Inositol, in any form alone or in combination with other therapies, should be considered experimental therapy in women with PCOS with infertility. The benefits and risks are currently too uncertain to recommend these agents as fertility therapies. There is limited evidence with uncertain results regarding the effect of inositol on ovulation, clinical pregnancy, and live birth rates, and the side effects and safety are not well known.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation regarding anti-obesity pharmacological agents in PCOS?",
    "answer": "Anti-obesity agents in PCOS are recommended for reproductive outcomes only in research settings to establish their efficacy and safety. This indicates that their use outside of research is not currently supported due to a lack of established safety and effectiveness.",
    "is_verified": 1
  },
  {
    "question": "What are the diagnostic criteria for PCOS according to the 2018 International Evidence-based Guideline?",
    "answer": "PCOS should be diagnosed using the 2018 International Evidence-based Guideline criteria, which require the presence of two of the following: i) clinical/biochemical hyperandrogenism; ii) ovulatory dysfunction; and iii) polycystic ovaries on ultrasound. Alternatively, anti-Müllerian hormone (AMH) can now be used instead of ultrasound, with the exclusion of other aetiologies. In cases of irregular menstrual cycles and hyperandrogenism, diagnosis is simplified and ultrasound or AMH are not required for diagnosis.",
    "is_verified": 1
  },
  {
    "question": "What baseline investigations are recommended for the diagnosis of PCOS?",
    "answer": "The recommended baseline investigations for the diagnosis of PCOS include: i) Endocrine profile and pelvic ultrasound scan; ii) Assessment of BMI, BP & glycemic status (OGTT / HbA1c); iii) Routine preconception assessments (Rubella immunity, infection screen, etc.); iv) Additional investigations such as semen analysis and consideration of tubal patency assessment.",
    "is_verified": 1
  },
  {
    "question": "What lifestyle recommendations are suggested for individuals with PCOS?",
    "answer": "A healthy lifestyle encompassing healthy eating and regular physical activity should be recommended for all those with PCOS to limit adverse impacts on fertility and fertility treatment outcomes and to optimize health during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What are the off-label uses of Letrozole and Metformin in PCOS?",
    "answer": "Letrozole and Metformin are generally prescribed off-label for the treatment of Polycystic Ovary Syndrome (PCOS) as pharmaceutical companies have not applied for approval for these medications specifically for this condition. However, their off-label use is evidence-based and permitted in many countries, where health professionals are expected to inform women about the evidence, potential concerns, and side effects of these treatments.",
    "is_verified": 1
  },
  {
    "question": "How does Metformin compare to Letrozole and Gonadotrophins in terms of efficacy and cost for treating PCOS?",
    "answer": "Metformin has lower efficacy, cost, and multiple pregnancy rates compared to Letrozole and Gonadotrophins. In contrast, Gonadotrophins have higher efficacy, higher cost, and higher multiple pregnancy rates. Both Metformin and Letrozole may serve as alternative first-line choices for informed women.",
    "is_verified": 1
  },
  {
    "question": "What is the role of In Vitro Fertilization (IVF) in treating infertility associated with PCOS?",
    "answer": "In Vitro Fertilization (IVF) is considered a third-line treatment for infertility in women with PCOS, unless there are other infertility factors present, such as male factor infertility or tubal issues. Specific protocols for PCOS are recommended to minimize the risk of ovarian hyperstimulation syndrome, and in vitro maturation may be considered if available.",
    "is_verified": 1
  },
  {
    "question": "What are the medical treatment options for PCOS-related infertility?",
    "answer": "Medical treatment options for infertility related to PCOS include Clomiphene citrate combined with Metformin (preferred over Clomiphene alone), Clomiphene alone, Metformin (which is low cost and low efficacy with no monitoring), or Gonadotrophins (which are high cost, have a high efficacy, and require monitoring). These treatments are categorized into first-line and second-line medical treatments based on their efficacy and cost.",
    "is_verified": 1
  },
  {
    "question": "What considerations should be made when using Gonadotrophins for treating PCOS?",
    "answer": "When using Gonadotrophins for treating PCOS, it is important to have ultrasound monitoring and to adjust the dose as required to optimize treatment outcomes.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of shared decision-making in the treatment of infertility in women with PCOS?",
    "answer": "Shared decision-making is significant in the treatment of infertility in women with PCOS as it involves considering the woman's age, resources, and personal preferences when deciding on treatment options, including the potential transition to IVF after repeated cycles of other treatments.",
    "is_verified": 1
  },
  {
    "question": "What lifestyle considerations are recommended for women with PCOS seeking to optimize preconception health?",
    "answer": "Women with PCOS are advised to optimize their preconception health and lifestyle as part of their treatment plan for infertility, although specific lifestyle changes are not detailed in the excerpt.",
    "is_verified": 1
  },
  {
    "question": "What is the focus of the International evidence-based guideline for the assessment and management of polycystic ovary syndrome?",
    "answer": "The guideline focuses on the assessment and management of polycystic ovary syndrome (PCOS), providing evidence-based recommendations for healthcare professionals.",
    "is_verified": 1
  },
  {
    "question": "Who are the authors of the International PCOS Guideline 2023?",
    "answer": "The authors of the guideline include Helena Teede and others from Monash University.",
    "is_verified": 1
  },
  {
    "question": "What organization is associated with the International PCOS Guideline 2023?",
    "answer": "The guideline is associated with the NHMRC Centre for Research Excellence in Women’s Health in Reproductive Life.",
    "is_verified": 1
  },
  {
    "question": "What is insulin resistance and its relevance in PCOS?",
    "answer": "Insulin resistance is recognized as a key feature of Polycystic Ovary Syndrome (PCOS). It is a condition where the body's cells become less responsive to insulin, leading to higher blood sugar levels. However, routinely available measures of insulin resistance are often inaccurate, and clinical measurement is not currently recommended for diagnosing PCOS.",
    "is_verified": 1
  },
  {
    "question": "What are the recommended assessments and management strategies for women diagnosed with PCOS?",
    "answer": "Once diagnosed with PCOS, assessment and management should address various features including reproductive, metabolic, cardiovascular, dermatologic, sleep, and psychological aspects. A lifelong health plan is recommended, focusing on a healthy lifestyle, prevention of excess weight gain, optimization of fertility and preconception risk factors, and prevention and treatment of diverse clinical features such as metabolic risk factors, diabetes, cardiovascular disease, and sleep disorders, which are all increased in PCOS.",
    "is_verified": 1
  },
  {
    "question": "What are the pregnancy risks associated with PCOS?",
    "answer": "PCOS should be considered a high-risk condition during pregnancy, necessitating identification and monitoring of affected women. Additionally, there is an increased premenopausal risk of endometrial cancer associated with PCOS, although the absolute risks remain low.",
    "is_verified": 1
  },
  {
    "question": "How does PCOS affect mental health?",
    "answer": "Women with PCOS experience significantly increased symptoms of depression and anxiety, which should be screened for in all affected individuals. Psychological assessment and therapy may be indicated, and there is a need for greater awareness of psychological features, including eating disorders and their impacts on body image and quality of life.",
    "is_verified": 1
  },
  {
    "question": "What lifestyle recommendations are made for women with PCOS?",
    "answer": "A supported healthy lifestyle is vital throughout the lifespan for women with PCOS. This includes a strong focus on overall health, prevention of weight gain, and, if necessary, weight management to mitigate the risks associated with the condition.",
    "is_verified": 1
  },
  {
    "question": "What is the first line pharmacological treatment for menstrual irregularity and hyperandrogenism in PCOS?",
    "answer": "Combined oral contraceptive pills are the first line pharmacological treatment for menstrual irregularity and hyperandrogenism in PCOS, with a preference for lower ethinyl estradiol dose preparations and those with fewer side effects.",
    "is_verified": 1
  },
  {
    "question": "What is the role of Metformin in the treatment of PCOS?",
    "answer": "Metformin is recommended primarily for metabolic features in PCOS and has greater efficacy than inositol, which offers limited clinical benefits. However, Metformin is not routinely recommended for use in pregnant women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What therapies are considered for infertility in women with PCOS?",
    "answer": "Letrozole is the preferred first line pharmacological infertility therapy, often used in combination with clomiphene and metformin. Gonadotrophins or ovarian surgery are considered second line therapies, while in vitro fertilization (IVF) may be offered as a third line therapy if other ovulation induction therapies have failed.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation regarding embryo transfer in women with PCOS undergoing IVF?",
    "answer": "Given the underlying risk for pregnancy complications in PCOS, single embryo transfer should be preferred during IVF procedures.",
    "is_verified": 1
  },
  {
    "question": "What is the effectiveness of mechanical laser therapy in PCOS?",
    "answer": "Mechanical laser therapy is effective for hair reduction in some subgroups of women with PCOS.",
    "is_verified": 1
  },
  {
    "question": "What is the role of anti-androgens in the treatment of PCOS?",
    "answer": "Anti-androgens have a limited role in the treatment of PCOS, primarily used where other therapies are ineffective or contraindicated.",
    "is_verified": 1
  },
  {
    "question": "What considerations are there for anti-obesity agents and bariatric/metabolic surgery in PCOS?",
    "answer": "Anti-obesity agents and bariatric/metabolic surgery may be considered based on general population guidelines, balancing the potential for benefits and side effects.",
    "is_verified": 1
  },
  {
    "question": "What is the focus of the international partnership mentioned in the excerpt?",
    "answer": "The focus of the international partnership is to optimize health outcomes for women with a common, heterogeneous, and much neglected condition.",
    "is_verified": 1
  },
  {
    "question": "What organization is mentioned in relation to the guideline processes?",
    "answer": "The National Health Medical Research Council (NHMRC) is mentioned in relation to the guideline processes.",
    "is_verified": 1
  },
  {
    "question": "What medical organizations are mentioned in the excerpt?",
    "answer": "The excerpt mentions several medical organizations including the Australian National Health and Medical Research Council (NHMRC), American Society for Reproductive Medicine (ASRM), Endocrine Society (ENDO), European Society for Endocrinology (ESE), European Society of Human Reproduction and Embryology (ESHRE), and the Androgen Excess and Polycystic Ovary Syndrome Society (AEPCOS).",
    "is_verified": 1
  },
  {
    "question": "What is the focus of the Centre for Research Excellence in Polycystic Ovary Syndrome (CRE PCOS)?",
    "answer": "The Centre for Research Excellence in Polycystic Ovary Syndrome (CRE PCOS) focuses on research related to polycystic ovary syndrome, a common endocrine disorder affecting women's reproductive health.",
    "is_verified": 1
  },
  {
    "question": "What type of support is provided by the collaborating organizations mentioned in the excerpt?",
    "answer": "The collaborating organizations provide in-kind support for the international guideline effort related to women's health and reproductive life, particularly in the context of polycystic ovary syndrome.",
    "is_verified": 1
  },
  {
    "question": "What is the role of the Australian National Health Medical Research Council (NHMRC) in the provided excerpt?",
    "answer": "The NHMRC primarily funded the work mentioned in the excerpt, indicating its involvement in supporting medical research and guidelines.",
    "is_verified": 1
  },
  {
    "question": "What are some of the medical organizations mentioned in the excerpt that provided funding?",
    "answer": "The excerpt mentions the American Society for Reproductive Medicine, Endocrine Society, European Society of Human Reproduction and Embryology, and the European Society for Endocrinology as organizations that provided partnership funding.",
    "is_verified": 1
  },
  {
    "question": "What condition is discussed in the reference provided in the excerpt?",
    "answer": "The reference discusses Polycystic Ovary Syndrome (PCOS), describing it as a complex condition with psychological, reproductive, and metabolic manifestations that impacts health across the lifespan.",
    "is_verified": 1
  },
  {
    "question": "What is polycystic ovary syndrome (PCOS)?",
    "answer": "Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age, characterized by irregular menstrual periods, excess hair growth, acne, and obesity. It is associated with metabolic issues and can lead to infertility if not managed properly.",
    "is_verified": 1
  },
  {
    "question": "What are the common issues faced by women with PCOS according to the studies?",
    "answer": "Women with polycystic ovary syndrome often face delayed diagnosis and a lack of information, which can lead to dissatisfaction with their healthcare experience. There are also gaps in knowledge among physicians regarding the diagnostic criteria and management of PCOS.",
    "is_verified": 1
  },
  {
    "question": "What recommendations exist for the management of PCOS?",
    "answer": "The international evidence-based guideline for the assessment and management of polycystic ovary syndrome provides recommendations for healthcare providers on how to effectively diagnose and manage the condition, emphasizing the importance of individualized care and patient education.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of the institutions and researchers mentioned in the excerpt?",
    "answer": "The excerpt lists various researchers and institutions involved in medical research, particularly in the fields of fertility, women's health, and related areas. These include notable universities and hospitals from around the world, indicating a collaborative effort in advancing medical knowledge and practices related to fertility and reproductive health.",
    "is_verified": 1
  },
  {
    "question": "What institutions are mentioned in the excerpt that are related to medical fields?",
    "answer": "The excerpt mentions several institutions related to medical fields, including Harp Family Medical in Australia, Children's Hospital of Pittsburgh of UPMC, Reproductive Medical Centre at Sun Yat-Sen Memorial Hospital in China, and Icahn School of Medicine at Mount Sinai in the USA.",
    "is_verified": 1
  },
  {
    "question": "Who are some of the individuals associated with medical institutions in the excerpt?",
    "answer": "Individuals associated with medical institutions include Mala Thondan from Harp Family Medical, Selma Witchel from Children's Hospital of Pittsburgh, Dongzi Yang from Reproductive Medical Centre, and Maryam Kazemi from Icahn School of Medicine at Mount Sinai.",
    "is_verified": 1
  }
]
